Qingliang Wang

2.7k total citations · 1 hit paper
66 papers, 1.9k citations indexed

About

Qingliang Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qingliang Wang has authored 66 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qingliang Wang's work include Thyroid Cancer Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Qingliang Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Qingliang Wang collaborates with scholars based in China, United States and Hong Kong. Qingliang Wang's co-authors include Donald J. Zack, Shiming Chen, Debra J. Gilbert, Nancy A. Jenkins, Zuqin Nie, Hui Sun, Neal G. Copeland, Gregory G. Lennon, Xiu‐Wu Bian and Jimo Borjigin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and SHILAP Revista de lepidopterología.

In The Last Decade

Qingliang Wang

60 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crx, a Novel Otx-like Paired-Homeodomain Protein, Binds to and Transactivates Photoreceptor Cell-Specific Genes

1997 592 citations Shiming Chen, Qingliang Wang et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingliang Wang China	22	1.1k	394	353	299	191	66	1.9k
Anika Agarwal United States	21	965 0.9×	635 1.6×	286 0.8×	643 2.2×	270 1.4×	26	2.3k
Hirotaka Koizumi Japan	20	635 0.6×	355 0.9×	170 0.5×	169 0.6×	207 1.1×	53	1.4k
Yuji Gunji Japan	19	1.3k 1.1×	506 1.3×	163 0.5×	431 1.4×	270 1.4×	40	2.1k
Edward J. Dropcho United States	29	665 0.6×	390 1.0×	291 0.8×	229 0.8×	208 1.1×	58	2.7k
Christopher B. Chambers United States	18	1.1k 1.0×	420 1.1×	156 0.4×	558 1.9×	142 0.7×	51	2.1k
Barbara A. Christy United States	23	1.4k 1.3×	435 1.1×	375 1.1×	218 0.7×	210 1.1×	47	2.4k
Susan Chi United States	35	1.6k 1.5×	443 1.1×	104 0.3×	308 1.0×	217 1.1×	121	3.6k
Bret C. Mobley United States	23	727 0.7×	171 0.4×	209 0.6×	193 0.6×	121 0.6×	67	1.7k
Francisco Sánchez‐Sánchez Spain	22	842 0.8×	236 0.6×	153 0.4×	169 0.6×	87 0.5×	55	1.6k
Suzanne Lam Netherlands	16	838 0.7×	530 1.3×	257 0.7×	119 0.4×	138 0.7×	22	1.3k

Countries citing papers authored by Qingliang Wang

Since Specialization

Citations

This map shows the geographic impact of Qingliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingliang Wang more than expected).

Fields of papers citing papers by Qingliang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingliang Wang. The network helps show where Qingliang Wang may publish in the future.

Co-authorship network of co-authors of Qingliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingliang Wang. A scholar is included among the top collaborators of Qingliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingliang Wang. Qingliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qingliang, et al.. (2025). Identification of KRBA2 as a probable prognostic biomarker correlated with immune infiltration in kidney clear cell carcinoma. Current Urology. 19(6). 403–418.

Cai, Qiang, Congcong Xu, Hao Liang, et al.. (2025). Global trends and regional differences of hepatoblastoma: a systematic analysis and predictions to 2035 based on the global burden of disease study 2021. BMC Public Health. 25(1). 3227–3227.

Wang, Qingliang, et al.. (2025). Biomimetic Diselenide‐Sonosensitizer Nanoplatform for Enhanced Sonodynamic Therapy and In Situ Remodeling Immunosuppressive Microenvironment via Activating Innate and Adaptive Immunotherapy. Advanced Healthcare Materials. 14(6). e2403998–e2403998. 7 indexed citations

Jian, Wencheng, et al.. (2024). The Role of Lactate Dehydrogenase in Exploring the Immune Evasion in HCC Patients Who Underwent TACE: Implications for Clinical Application. Journal of Hepatocellular Carcinoma. Volume 11. 1823–1833. 1 indexed citations

Wang, Qingliang, et al.. (2024). Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 792–792.

Zhang, Peng, et al.. (2024). Enhanced recovery after surgery in percutaneous transhepatic cholangioscopic lithotripsy for patients with hepatolithiasis and choledocholithiasis. SHILAP Revista de lepidopterología. 20. 38–44.

Li, Qijian, Ningning Yu, Xiaowen Chen, et al.. (2024). Co doped V2O5 hollow microsphere as high-performance cathode for aqueous zinc-ion battery. Journal of Power Sources. 628. 235895–235895. 6 indexed citations

Wang, Zicheng, Yingkun Xu, Peizhi Zhang, et al.. (2023). Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma. BMC Urology. 23(1). 45–45. 2 indexed citations

Wang, Qingliang, Xiaojie Li, Wenting Tang, et al.. (2022). Differential Gene Sets Profiling in Gram-Negative and Gram-Positive Sepsis. Frontiers in Cellular and Infection Microbiology. 12. 801232–801232. 7 indexed citations

10.

Wang, Zicheng, et al.. (2022). ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway. Journal of Oncology. 2022. 1–24. 9 indexed citations

11.

Zhang, Peng, Xiaojie Li, Ruomi Guo, et al.. (2021). Idiopathic acute superior mesenteric venous thrombosis after renal transplantation: A case report. World Journal of Clinical Cases. 9(32). 9896–9902. 1 indexed citations

12.

Yin, Ying, et al.. (2019). Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway. Molecular Medicine Reports. 20(1). 409–416. 13 indexed citations

13.

Hu, Kunpeng, Pinzhu Huang, Hui Luo, et al.. (2017). Mammalian‐enabled (MENA) protein enhances oncogenic potential and cancer stem cell‐like phenotype in hepatocellular carcinoma cells. FEBS Open Bio. 7(8). 1144–1153. 14 indexed citations

14.

Wang, Qingliang, et al.. (2016). Adult-onset atopic dermatitis. Chinese Journal of Dermatology. 49(6). 444–447. 2 indexed citations

15.

Duan, Weili, Lutao Du, Xiumei Jiang, et al.. (2016). Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 7(48). 78850–78858. 104 indexed citations

16.

Li, Jing, Liang Wang, Chunjing Bian, et al.. (2010). Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway. Cancer Science. 101(11). 2417–2424. 50 indexed citations

17.

Ping, Yi‐Fang, Shi‐Cang Yu, Jianhong Chen, et al.. (2009). Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. Biochemical and Biophysical Research Communications. 381(3). 448–452. 15 indexed citations

18.

Bian, Xiu‐Wu, Jianhong Chen, Yi‐Fang Ping, et al.. (2007). PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL. Neurosurgery. 61(3). 570–579. 100 indexed citations

19.

Chen, Shiming, Qingliang Wang, Zuqin Nie, et al.. (1997). Crx, a Novel Otx-like Paired-Homeodomain Protein, Binds to and Transactivates Photoreceptor Cell-Specific Genes. Neuron. 19(5). 1017–1030. 592 indexed citations breakdown →

20.

Wang, Qingliang, et al.. (1988). Treatment of Giant Cell Tumor of Bone.. PubMed Central. 8. 39–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact